Thursday, July 25, 2013
The Michael J. Fox Foundation for Parkinson's Research has
taken two major steps toward its goal of identifying clinical populations in
which new therapies for Parkinson's disease can be tested. Last week, the
foundation made available the first set of data and samples from its LRRK2
Cohort Consortium and presented preliminary data from its Parkinson's
Progression Marker Initiative.
PD and AD
Haas, M.J. SciBX 6(28); doi:10.1038/scibx.2013.710
Published online July 25, 2013
1. Haas, M.J. SciBX 4(29); doi:10.1038/scibx.2011.813
Alzheimer's Association, Chicago, Ill.
The Michael J. Fox Foundation for Parkinson's Research, New York, N.Y.
Yale University, New Haven, Conn.